Department of Radiology, Cardiac and Vascular Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Vasc Surg. 2011 Mar;53(3):725-31. doi: 10.1016/j.jvs.2010.09.028. Epub 2010 Dec 10.
Ethanol embolotherapy is one of the established methods in the treatment of extremity arteriovenous malformations (AVMs). The purpose of this study was to report the application of this method to hand AVMs and to assess retrospectively the therapeutic outcomes and complications.
From December 1998 to March 2009, we treated 31 patients with hand AVMs (16 women, 15 men, age range, 5-51 years; mean age, 27 years). With the patients under general anesthesia, they underwent staged ethanol embolotherapy (range, 1-11 sessions; mean, 2.8 sessions) by direct puncture and or intra-arterial approach. Therapeutic outcomes were evaluated by clinical responses of symptoms and signs, as well as the degree of devascularization on angiography. We also divided the patients into three groups according to the extent of involvement: a group involving fingers (n = 14), a group involving fingers and parts of the palm (n = 9), and a group involving parts of the palm (n = 8) and compared the therapeutic outcomes and complications among groups.
One patient (3%) was cured, 22 patients (73%) showed improvement, and 7 patients (23%) showed no change or aggravation after the treatment. One patient was lost to follow-up. Nineteen patients (61%) had one or more complications, including skin necrosis in 14 patients (45%), bullae in 7 patients (23%), joint stiffness or contracture in 6 patients (19%), and transient nerve palsy in 4 patients (13%). All of the complications were resolved completely after 1 to 8 months' (average, 3.4 months) follow-up, except in 2 patients who underwent amputation. According to the location of AVMs, rates of therapeutic benefit and complications were 93% and 64% in the group involving fingers, 38% and 78% in the group involving fingers and the palm, and 88% and 38% in the group involving the palm, respectively.
Ethanol embolotherapy of hand AVMs improves symptoms in a certain percentage of patients with a relatively high risk of complications. According to the extent of AVMs, there was a trend toward a higher complication rate in treatment of AVMs involving fingers and a lower rate of therapeutic benefit in AVMs involving both the fingers and the palm.
乙醇栓塞疗法是治疗肢体动静脉畸形(AVM)的既定方法之一。本研究的目的是报告该方法在手 AVM 中的应用,并回顾性评估治疗效果和并发症。
自 1998 年 12 月至 2009 年 3 月,我们治疗了 31 例手部 AVM 患者(女 16 例,男 15 例,年龄 5-51 岁;平均年龄 27 岁)。患者全身麻醉下,经直接穿刺或动脉内入路分阶段进行乙醇栓塞治疗(范围 1-11 次;平均 2.8 次)。通过临床症状和体征的反应以及血管造影的去血管化程度来评估治疗效果。我们还根据受累范围将患者分为三组:一组涉及手指(n=14),一组涉及手指和手掌部分(n=9),一组涉及手掌部分(n=8),并比较了三组之间的治疗效果和并发症。
1 例(3%)患者治愈,22 例(73%)患者症状改善,7 例(23%)患者治疗后无变化或加重。1 例患者失访。19 例(61%)患者发生 1 种或多种并发症,包括 14 例(45%)皮肤坏死、7 例(23%)水疱、6 例(19%)关节僵硬或挛缩、4 例(13%)短暂性神经麻痹。所有并发症在 1-8 个月(平均 3.4 个月)的随访后完全消退,仅 2 例患者截肢。根据 AVM 的位置,涉及手指的治疗效果和并发症发生率分别为 93%和 64%,涉及手指和手掌的治疗效果和并发症发生率分别为 38%和 78%,涉及手掌的治疗效果和并发症发生率分别为 88%和 38%。
乙醇栓塞治疗手部 AVM 可改善一定比例患者的症状,但并发症风险相对较高。根据 AVM 的范围,涉及手指的 AVM 治疗并发症发生率较高,治疗效果较差,而同时涉及手指和手掌的 AVM 治疗效果较好。